Rosiglitazone is an antidiabetic drug. The maleic acid salt of its racemic mixture is sold by GlaxoSmithKline under the trade name Avandia. In July, the FDA voted to keep Avandia available despite evidence linking it to an increased risk of heart disease. In September, FDA limited its use, and the European Medicines Agency suspended marketing of the drug.
Learn more about this molecule from CAS, the most authoritative and comprehensive source for chemical information.
Molecule of the Week needs your suggestions!
If your favorite molecule is not in our archive, please send us a message. The molecule can be notable for its current or historical importance or for any quirky reason. Thank you!
Stay Ahead of the Chemistry Curve
Learn how ACS can help you stay ahead in the world of chemistry.
